ASX - By Stock
|
ATX |
Re:
Ann: Sustained Reduction in Tumour Size Seen In Pancreatic Trial
|
|
petesherl
|
46 |
11K |
0 |
28/07/24 |
28/07/24 |
ASX - By Stock
|
46
|
11K
|
0
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Sustained Reduction in Tumour Size Seen In Pancreatic Trial
|
|
petesherl
|
46 |
11K |
4 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
46
|
11K
|
4
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Sustained Reduction in Tumour Size Seen In Pancreatic Trial
|
|
petesherl
|
46 |
11K |
9 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
46
|
11K
|
9
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Substantial Holder Notice - Blueflag Holding Pty Ltd
|
|
petesherl
|
4 |
1.3K |
3 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
4
|
1.3K
|
3
|
|
ASX - By Stock
|
ATX |
Re:
Ann: $4.27m Offer Successfully Completed and ACCENT Trial Update
|
|
petesherl
|
3 |
1.1K |
1 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
3
|
1.1K
|
1
|
|
ASX - By Stock
|
ARU |
Re:
Arafura Rare Earths Ltd
|
|
petesherl
|
1.1K |
521K |
3 |
12/05/24 |
12/05/24 |
ASX - By Stock
|
1.1K
|
521K
|
3
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
petesherl
|
5 |
1.9K |
0 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
5
|
1.9K
|
0
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Update on ACCENT Trial in Pancreatic Cancer
|
|
petesherl
|
44 |
14K |
0 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
44
|
14K
|
0
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Update on ACCENT Trial in Pancreatic Cancer
|
|
petesherl
|
44 |
14K |
0 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
44
|
14K
|
0
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Trading Halt
|
|
petesherl
|
21 |
7.5K |
0 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
21
|
7.5K
|
0
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Trading Halt
|
|
petesherl
|
21 |
7.5K |
1 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
21
|
7.5K
|
1
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Trading Halt
|
|
petesherl
|
21 |
7.5K |
1 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
21
|
7.5K
|
1
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Update on ACCENT Trial in Pancreatic Cancer
|
|
petesherl
|
44 |
14K |
1 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
44
|
14K
|
1
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Update on ACCENT Trial in Pancreatic Cancer
|
|
petesherl
|
44 |
14K |
0 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
44
|
14K
|
0
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Update on ACCENT Trial in Pancreatic Cancer
|
|
petesherl
|
44 |
14K |
4 |
31/03/24 |
31/03/24 |
ASX - By Stock
|
44
|
14K
|
4
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Update on ACCENT Trial in Pancreatic Cancer
|
|
petesherl
|
44 |
14K |
0 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
44
|
14K
|
0
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Update on ACCENT Trial in Pancreatic Cancer
|
|
petesherl
|
44 |
14K |
0 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
44
|
14K
|
0
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
petesherl
|
58 |
16K |
0 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
58
|
16K
|
0
|
|
ASX - By Stock
|
ARU |
Re:
General Discussion
|
|
petesherl
|
2.2K |
1.0M |
4 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
2.2K
|
1.0M
|
4
|
|
ASX - By Stock
|
ATX |
Re:
Ann: ACCENT Trial Recruitment Update
|
|
petesherl
|
21 |
7.4K |
1 |
29/10/23 |
29/10/23 |
ASX - By Stock
|
21
|
7.4K
|
1
|
|
ASX - By Stock
|
ARU |
Re:
General Discussion
|
|
petesherl
|
2.2K |
1.0M |
3 |
12/10/23 |
12/10/23 |
ASX - By Stock
|
2.2K
|
1.0M
|
3
|
|
ASX - By Stock
|
ARU |
Offtake and Finance : timing
|
|
petesherl
|
4 |
2.7K |
0 |
05/09/23 |
05/09/23 |
ASX - By Stock
|
4
|
2.7K
|
0
|
|
ASX - By Stock
|
ARU |
Re:
Ann: Options Quotation
|
|
petesherl
|
19 |
11K |
4 |
22/08/23 |
22/08/23 |
ASX - By Stock
|
19
|
11K
|
4
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
petesherl
|
14K |
5.1M |
10 |
27/07/23 |
27/07/23 |
ASX - By Stock
|
14K
|
5.1M
|
10
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Botanix Capital Raising to Extinguish Milestone & Royalty
|
|
petesherl
|
116 |
37K |
7 |
21/07/23 |
21/07/23 |
ASX - By Stock
|
116
|
37K
|
7
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Trading Halt
|
|
petesherl
|
208 |
68K |
12 |
19/07/23 |
19/07/23 |
ASX - By Stock
|
208
|
68K
|
12
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Trading Halt
|
|
petesherl
|
208 |
68K |
11 |
19/07/23 |
19/07/23 |
ASX - By Stock
|
208
|
68K
|
11
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Trading Halt
|
|
petesherl
|
208 |
68K |
18 |
19/07/23 |
19/07/23 |
ASX - By Stock
|
208
|
68K
|
18
|
|
ASX - By Stock
|
ARU |
Re:
Ann: Indicative financing support from Export Development Canada
|
|
petesherl
|
89 |
40K |
3 |
22/06/23 |
22/06/23 |
ASX - By Stock
|
89
|
40K
|
3
|
|
ASX - By Stock
|
ARU |
Re:
Ann: Indicative financing support from Export Development Canada
|
|
petesherl
|
89 |
40K |
7 |
22/06/23 |
22/06/23 |
ASX - By Stock
|
89
|
40K
|
7
|
|
ASX - By Stock
|
ARU |
Re:
Ann: Indicative financing support from Export Development Canada
|
|
petesherl
|
89 |
40K |
12 |
20/06/23 |
20/06/23 |
ASX - By Stock
|
89
|
40K
|
12
|
|
ASX - By Stock
|
ANR |
Re:
Ann: Anatara Update on GaRP Irritable Bowel Syndrome Trial
|
|
petesherl
|
5 |
3.2K |
0 |
07/06/23 |
07/06/23 |
ASX - By Stock
|
5
|
3.2K
|
0
|
|
ASX - By Stock
|
ATX |
Re:
Ann: AMP945 and FOLFIRINOX active in model of Pancreatic Cancer
|
|
petesherl
|
24 |
9.0K |
0 |
31/05/23 |
31/05/23 |
ASX - By Stock
|
24
|
9.0K
|
0
|
|
ASX - By Stock
|
ATX |
Re:
Ann: AMP945 and FOLFIRINOX active in model of Pancreatic Cancer
|
|
petesherl
|
24 |
9.0K |
2 |
30/05/23 |
30/05/23 |
ASX - By Stock
|
24
|
9.0K
|
2
|
|
ASX - By Stock
|
ATX |
Re:
Ann: ACCENT Trial Recruitment Progress
|
|
petesherl
|
16 |
5.0K |
1 |
09/05/23 |
09/05/23 |
ASX - By Stock
|
16
|
5.0K
|
1
|
|
ASX - By Stock
|
BOT |
Re:
Ann: March 2023 Quarterly Activities Report and Appendix 4C
|
|
petesherl
|
33 |
10K |
11 |
30/04/23 |
30/04/23 |
ASX - By Stock
|
33
|
10K
|
11
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Presentation to Accompany AI Development Program Update
|
|
petesherl
|
68 |
32K |
10 |
27/04/23 |
27/04/23 |
ASX - By Stock
|
68
|
32K
|
10
|
|
ASX - By Stock
|
ARU |
Re:
News: ARU Arafura Rare Earths Enters Into Agreement For Supply Of Sulphuric Acid Plant For Its...
|
|
petesherl
|
13 |
10K |
4 |
05/03/23 |
05/03/23 |
ASX - By Stock
|
13
|
10K
|
4
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
petesherl
|
1.5K |
602K |
1 |
24/02/23 |
24/02/23 |
ASX - By Stock
|
1.5K
|
602K
|
1
|
|
ASX - By Stock
|
ATX |
Re:
Ann: ATX - US Conference Presentation
|
|
petesherl
|
1 |
966 |
2 |
23/02/23 |
23/02/23 |
ASX - By Stock
|
1
|
966
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Ann: ZIRCON Ph III Renal Cancer Study to be Presented at ASCO GU
|
|
petesherl
|
41 |
16K |
1 |
17/02/23 |
17/02/23 |
ASX - By Stock
|
41
|
16K
|
1
|
|
ASX - By Stock
|
ARU |
Re:
Ann: Notice of General Meeting/Proxy Form
|
|
petesherl
|
15 |
9.5K |
0 |
19/12/22 |
19/12/22 |
ASX - By Stock
|
15
|
9.5K
|
0
|
|
ASX - By Stock
|
ARU |
Re:
Ann: Notice of General Meeting/Proxy Form
|
|
petesherl
|
15 |
9.5K |
10 |
19/12/22 |
19/12/22 |
ASX - By Stock
|
15
|
9.5K
|
10
|
|
ASX - By Stock
|
ATX |
Re:
Ann: ACCENT Trial Recruitment Progress
|
|
petesherl
|
24 |
7.9K |
10 |
30/11/22 |
30/11/22 |
ASX - By Stock
|
24
|
7.9K
|
10
|
|
ASX - By Stock
|
ATX |
Re:
Ann: ACCENT Trial Recruitment Progress
|
|
petesherl
|
24 |
7.9K |
8 |
30/11/22 |
30/11/22 |
ASX - By Stock
|
24
|
7.9K
|
8
|
|
ASX - By Stock
|
ATX |
Re:
Ann: ACCENT Trial Recruitment Progress
|
|
petesherl
|
24 |
7.9K |
0 |
29/11/22 |
29/11/22 |
ASX - By Stock
|
24
|
7.9K
|
0
|
|
ASX - By Stock
|
BCT |
Re:
4th Stocks Down Under Semiconductor Conference ... 15 November 2022
|
|
petesherl
|
15 |
6.1K |
0 |
04/11/22 |
04/11/22 |
ASX - By Stock
|
15
|
6.1K
|
0
|
|
ASX - By Stock
|
ARU |
Re:
ARU Chart Thread
|
|
petesherl
|
2.9K |
1.4M |
2 |
30/06/22 |
30/06/22 |
ASX - By Stock
|
2.9K
|
1.4M
|
2
|
|
ASX - By Stock
|
ARU |
Re:
How high can ARU sp go? after we start production ?
|
|
petesherl
|
128 |
87K |
5 |
09/06/22 |
09/06/22 |
ASX - By Stock
|
128
|
87K
|
5
|
|
ASX - By Stock
|
ARU |
Re:
Ann: Mandated Lead Arrangers Appointed for Nolans Project
|
|
petesherl
|
20 |
12K |
1 |
28/04/22 |
28/04/22 |
ASX - By Stock
|
20
|
12K
|
1
|
|